Gary Gaffney

3.6k total citations
62 papers, 2.5k citations indexed

About

Gary Gaffney is a scholar working on Cognitive Neuroscience, Pharmacology and Clinical Psychology. According to data from OpenAlex, Gary Gaffney has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cognitive Neuroscience, 18 papers in Pharmacology and 15 papers in Clinical Psychology. Recurrent topics in Gary Gaffney's work include Cannabis and Cannabinoid Research (15 papers), Autism Spectrum Disorder Research (13 papers) and Obsessive-Compulsive Spectrum Disorders (11 papers). Gary Gaffney is often cited by papers focused on Cannabis and Cannabinoid Research (15 papers), Autism Spectrum Disorder Research (13 papers) and Obsessive-Compulsive Spectrum Disorders (11 papers). Gary Gaffney collaborates with scholars based in United States, Belgium and South Korea. Gary Gaffney's co-authors include Samuel Kuperman, Timothy L. Brown, Donald W. Black, Gary Milavetz, Andrew Spurgin, Rebecca L. Hartman, David A. Gorelick, Karl Sieg, Luke Y. Tsai and Jessica A. Hellings and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Gary Gaffney

60 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Gaffney United States 26 983 950 683 511 287 62 2.5k
Gahan Pandina United States 28 794 0.8× 635 0.7× 1.6k 2.4× 236 0.5× 225 0.8× 79 2.4k
Miguel Ángel Jiménez‐Arriero Spain 27 443 0.5× 541 0.6× 863 1.3× 241 0.5× 168 0.6× 92 2.2k
Allison M. Fox Australia 30 1.3k 1.3× 439 0.5× 598 0.9× 241 0.5× 50 0.2× 79 2.8k
Roberto Rodríguez–Jiménez Spain 34 698 0.7× 854 0.9× 1.4k 2.1× 300 0.6× 185 0.6× 158 3.7k
Hugh Rickards United Kingdom 40 1.2k 1.2× 1.4k 1.5× 1.3k 1.9× 179 0.4× 89 0.3× 124 4.1k
G. Ponce Spain 23 378 0.4× 379 0.4× 556 0.8× 217 0.4× 129 0.4× 72 1.7k
Maria Nobile Italy 28 897 0.9× 676 0.7× 917 1.3× 101 0.2× 337 1.2× 118 2.5k
Sten Levander Sweden 35 673 0.7× 1.5k 1.5× 1.3k 2.0× 152 0.3× 92 0.3× 146 3.7k
Wolfgang Sperling Germany 26 396 0.4× 252 0.3× 310 0.5× 231 0.5× 73 0.3× 101 1.9k
José Alvir United States 20 689 0.7× 372 0.4× 1.6k 2.3× 236 0.5× 134 0.5× 36 2.8k

Countries citing papers authored by Gary Gaffney

Since Specialization
Citations

This map shows the geographic impact of Gary Gaffney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Gaffney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Gaffney more than expected).

Fields of papers citing papers by Gary Gaffney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Gaffney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Gaffney. The network helps show where Gary Gaffney may publish in the future.

Co-authorship network of co-authors of Gary Gaffney

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Gaffney. A scholar is included among the top collaborators of Gary Gaffney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Gaffney. Gary Gaffney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Ryan, et al.. (2023). Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive. Accident Analysis & Prevention. 195. 107376–107376. 4 indexed citations
2.
Brown, Timothy L., et al.. (2022). Sensitivity to dose or blood levels of alprazolam in predicting driving impairment. Traffic Injury Prevention. 23(sup1). 1 indexed citations
3.
Brown, Timothy L., et al.. (2022). Perceived effects of cannabis: Generalizability of changes in driving performance. Traffic Injury Prevention. 23(sup1). S8–S13. 2 indexed citations
4.
Brown, Timothy L., Gary Gaffney, Gary Milavetz, et al.. (2022). A study of self-reported personal cannabis use and state legal status and associations with engagement in and perceptions of cannabis-impaired driving. Traffic Injury Prevention. 23(sup1). S183–S186. 3 indexed citations
5.
Brown, Timothy L., et al.. (2021). Perceived effects of cannabis and changes in driving performance under the influence of cannabis. Traffic Injury Prevention. 22(sup1). S8–S13. 6 indexed citations
6.
Brown, Timothy L., et al.. (2021). Cannabis use and reported effects on driving among adults in Iowa. Traffic Injury Prevention. 22(sup1). S187–S189. 2 indexed citations
7.
Brown, Timothy L., Christian Richard, Amir H. Meghdadi, et al.. (2020). EEG biomarkers acquired during a short, straight-line simulated drive to predict impairment from cannabis intoxication. Traffic Injury Prevention. 21(sup1). S130–S134. 7 indexed citations
8.
Hartman, Rebecca L., Timothy L. Brown, Gary Milavetz, et al.. (2015). Cannabis effects on driving lateral control with and without alcohol. Drug and Alcohol Dependence. 154. 25–37. 180 indexed citations
9.
Cook‐Wiens, Galen, et al.. (2012). A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. 43(5). 1017–1027. 8 indexed citations
10.
Black, Donald W. & Gary Gaffney. (2008). Subclinical Obsessive-Compulsive Disorder in Children and Adolescents: Additional Results From a “High-Risk” Study. CNS Spectrums. 13(S14). 54–61. 17 indexed citations
11.
Gaffney, Gary & Robin Parisotto. (2007). Gene Doping: A Review of Performance-Enhancing Genetics. Pediatric Clinics of North America. 54(4). 807–822. 25 indexed citations
12.
Black, Donald W., Gary Gaffney, Steven Schlosser, & Janelle Gabel. (1998). The Impact of Obsessive-Compulsive Disorder on the Family: Preliminary Findings. The Journal of Nervous and Mental Disease. 186(7). 440–442. 57 indexed citations
13.
Black, Donald W., et al.. (1998). Family History and Psychiatric Comorbidity in Persons With Compulsive Buying: Preliminary Findings. American Journal of Psychiatry. 155(7). 960–963. 157 indexed citations
14.
Sieg, Karl, Gary Gaffney, David F. Preston, & Jessica A. Hellings. (1995). SPECT Brain Imaging Abnormalities in Attention Deficit Hyperactivity Disorder. Clinical Nuclear Medicine. 20(1). 55–60. 124 indexed citations
15.
Gaffney, Gary, Karl Sieg, & Jessica A. Hellings. (1994). The MOVES: A Self-Rating Scale for Tourette's Syndrome. Journal of Child and Adolescent Psychopharmacology. 4(4). 269–280. 68 indexed citations
16.
Sieg, Karl, et al.. (1993). Tc-99m HMPAO SPECT Brain Imaging of Gilles de la Tourette??s Syndrome. Clinical Nuclear Medicine. 18(3). 255–255. 19 indexed citations
17.
Kuperman, Samuel, et al.. (1990). Neuroimaging in Child and Adolescent Psychiatry. Journal of the American Academy of Child & Adolescent Psychiatry. 29(2). 159–172. 25 indexed citations
18.
Gaffney, Gary, et al.. (1988). Morphological evidence for brainstem involvement in infantile autism. Biological Psychiatry. 24(5). 578–586. 93 indexed citations
19.
Gaffney, Gary, et al.. (1987). Midsagittal Magnetic Resonance Imaging of Autism. The British Journal of Psychiatry. 151(6). 831–833. 88 indexed citations
20.
Gaffney, Gary. (1987). Cerebellar Structure in Autism. Archives of Pediatrics and Adolescent Medicine. 141(12). 1330–1330. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026